4.2 Review

Multidimensional system biology: Genetic markers and proteomic biomarkers of adverse pregnancy outcome in preterm birth

Journal

AMERICAN JOURNAL OF PERINATOLOGY
Volume 25, Issue 3, Pages 175-187

Publisher

THIEME MEDICAL PUBL INC
DOI: 10.1055/s-2008-1061497

Keywords

preterm birth; genomics; proteomics

Funding

  1. NICHD NIH HHS [R01 HD047321-05, R01 HD047321-04, R01 HD047321-02, R01 HD047321-03, R01 HD047321-01, R01 HD047321] Funding Source: Medline
  2. EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047321] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Premature birth before 37 weeks of gestation is a significant public health problem. Each year, 4.5 million premature infants are born worldwide. Despite extensive research and a variety of interventions, the rate of preterm birth has steadily increased over the past 20 years and reached a high of 12.8% in 2006. The etiology of most preterm births remains elusive and is likely multifactorial, with many pathophysiological pathways involved, such as excessive stretching, oxidative stress, decidual hemorrhage, and infection. Genomics and proteomics have emerged to provide a better comprehension of the pathophysiological conditions leading to preterm birth, thereby providing a perspective for improving neonatal outcome.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available